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Purpose: To evaluate the relationship between bone mineral density (BMD) and 
magnetic susceptibility, and between proton density fat fraction and susceptibility, in 
inflamed trabecular bone.
Methods: Two different phantoms modeling the fat fraction (FF) and BMD values 
of healthy bone marrow and disease states were scanned using a multiecho gradient 
echo acquisition at 3T. After correction for fat‐water chemical shift, susceptibility 
mapping was performed, and susceptibility measurements were compared with 
BMD and FF values using linear regression. Patients with spondyloarthritis were 
scanned using the same protocol, and susceptibility values were calculated in areas 
of inflamed bone (edema) and fat metaplasia, both before and after accounting for the 
contribution of fat to the total susceptibility.
Results: Susceptibility values in the phantoms were accurately described by a 2D 
linear function, with a negative correlation between BMD and susceptibility and a 
positive correlation between FF and susceptibility (adjusted R2 = 0.77; P = 3·10−5). 
In patients, significant differences in susceptibility were observed between fat meta-
plasia and normal marrow, but these differences were eliminated by removing the fat 
contribution to the total susceptibility.
Conclusions: BMD and proton density fat fraction both influence the total suscepti-
bility of bone marrow and failure to account for the fat contribution could lead to 
errors in BMD quantification. We propose a method for removing the fat contribu-
tion from the total susceptibility, based on the observed linear relationship between 
susceptibility and FF. In inflamed bone, the overall increase in susceptibility in areas 
of fat metaplasia is at least partly due to increased fat content.
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1 |  INTRODUCTION
The spondyloarthritides are a group of inflammatory dis-
eases involving the spine, lower limb joints, and entheses.1 
New bone formation is a key feature of spondyloarthritis and 
causes spinal fusion, which contributes to pain, morbidity 
and disability. Conversely, spondyloarthritis patients may 
also suffer from bone loss in the form of osteoporosis,2 which 
contributes to increased fracture risk. Both disease processes 
cause alterations in bone mineral density (BMD), but this tis-
sue property is difficult to measure using the conventional 
T1‐weighted and T2‐weighted short tau inversion recovery 
(STIR) spin echo images that are widely used in clinical prac-
tice.3-6 Therefore, there is a clinical need for a quantitative, 
MRI‐based method for measuring BMD, and enable moni-
toring of new bone formation and bone loss in spondyloar-
thritis. An MRI‐based measure of BMD could also be useful 
for drug development, as there are several emerging therapies 
designed to inhibit bone formation in spondyloarthritis which 
currently lack a corresponding biomarker.7
Previously, Bray et al have proposed R2* as a quantita-
tive biomarker of trabecular BMD as the diamagnetic nature 
of bony trabeculae is expected to increase the rate of signal 
decay.8 They found a positive correlation between BMD and 
R2* in a fat‐water‐bone phantom (a mixture of peanut oil, 
agar solution, and granules of bovine bone matrix), and also 
significantly reduced R2* in areas of fat metaplasia (an area 
with increased bone marrow fat content occurring in regions 
of previous inflammation)9 in patients with spondyloarthri-
tis. However, R2* measurements are also influenced by vari-
ations in fat content, and the relationship between fat fraction 
(FF) measurements and R2* is complicated. This complex-
ity arises because fat contributes to dephasing both within 
the voxel, because of the multipeak fat spectrum,10,11 and 
in adjacent voxels, due to field inhomogeneities induced by 
magnetic susceptibility differences between water‐based and 
more paramagnetic fatty tissue.12-14 Furthermore, R2* mea-
surements cannot differentiate between para‐ and diamag-
netic structures.15
Recently, QSM15-17 has been investigated as an alterna-
tive method for quantifying BMD, with promising initial 
results.18,19 Dimov et al showed that susceptibility values 
were closely correlated with CT measurements of BMD 
in a porcine hoof, and were able to generate susceptibility 
maps in which cortical bone was homogenous and diamag-
netic, as expected from theory.18 However, susceptibil-
ity mapping is challenging in the presence of varying fat 
content, which is a characteristic feature of bone marrow 
inflammation in spondyloarthritis.8 Similarly to R2* mea-
surements, susceptibility estimates can be confounded by 
variations in fat content, which contribute to dephasing 
both within the voxel (due to chemical shift) and in ad-
jacent voxels (due to field inhomogeneities arising from 
the higher susceptibility of fat relative to water‐based 
tissue)12-14
In this study, we investigated the feasibility of QSM in 
inflamed bone marrow. The described QSM method was de-
signed to correct for the effect of chemical shift. We also at-
tempted to separate the fat contribution to total susceptibility 
so that “fat‐corrected” susceptibility measurements could be 
calculated. We evaluated the relationship between suscepti-
bility, FF, and BMD in dedicated phantoms containing fat, 
water, and trabecular bone. Furthermore, we evaluated the 
differences in susceptibility between areas of normal marrow, 
edema, and fat metaplasia in patients with spondyloarthritis.
2 |  METHODS
This study received ethical approval from the Queen Square 
Research Ethics Committee, London, United Kingdom 
(Research Ethics Committee reference 15/LO/1475). All pa-
tients gave written informed consent before study entry.
2.1 | Fat‐water‐bone phantom
We investigated the effect of FF and BMD on the calcu-
lated susceptibility using a fat‐water‐bone phantom (Figure 
1) consisting of varying concentrations of peanut oil, water 
and decellularized bovine trabecular bone matrix, as previ-
ously described.8 This phantom consists of twenty 5‐mL 
scintillation vials with FF measurements varying by row and 
BMD measurements varying by column (Figure 1B), with 
the range of FF and BMD values (0‐60% and 0‐150 mg/cm3, 
respectively) designed to cover the range of values expected 
in both normal marrow and disease states.8,20 As described 
previously, FF values in the phantom are calculated by vol-
ume and can be regarded as “reference” FF values rather than 
true proton density FF (PDFF) measurements, although the 
two parameters are expected to be very similar.8 The phan-
tom was immersed in distilled water (without doping) for 
scanning.
2.2 | Fat‐water phantom
A new fat‐water phantom was also created to examine the re-
lationship between susceptibility and fat fraction over the full 
FF range (0‐100%). Eleven 50‐mL centrifuge tubes were filled 
with mixtures of water and lard (rather than peanut oil as lard 
enabled us to create stable, solid phantoms which did not sepa-
rate at high FF), using sodium dodecyl sulfate as a surfactant, 
with FF values varying from 0% to 100%, in 10%‐increments. 
The final sodium dodecyl sulfate concentration in each phantom 
was 28 mM. Although this phantom allowed us to investigate 
the susceptibility at higher FF values, the dispersion of lard in 
water was poorer than that of peanut oil (in the fat‐water‐bone 
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phantom) leading to visible clumping in the tubes with FF 
50‐80%. Therefore, R2* values were not measured in this phan-
tom. Again, this phantom was immersed in distilled water for 
scanning.
2.3 | Patients and volunteers
This study was performed using data previously acquired by 
Bray et al8 in 18 patients (aged 12 to 30 years) diagnosed 
with or suspected of having spondyloarthritis. Patients with 
suspected spondyloarthritis were treated as controls if the 
subsequent clinical MRI scan and clinical assessment were 
found to be normal (n = 10).
2.4 | Data acquisition
MRI magnitude and phase images of the fat‐water‐bone 
phantom and the subjects were acquired by Bray et al8 at 3T 
(Ingenia, Philips Healthcare, NL) using a 3D spoiled gradi-
ent‐echo pulse sequence with monopolar readout gradients, 
with integrated posterior and anterior surface coils (each with 
16 channels). Images of the phantom were acquired coro-
nally, with the following parameters: field of view = 30 × 30 
× 80 cm3, resolution = 0.94 × 0.94 × 1.5 mm3, TE1 = 1.233 
ms, ΔTE = 1.951 ms, 6 echoes, TR = 23 ms, flip angle = 3°, 
bandwidth 1159 Hz/pixel. Images of the patients and volun-
teers consisted of tilted coronal slices through the sacroiliac 
joints (parallel to the long axis of the sacrum), field of view 
= 50 × 50 × 80 cm3, resolution = 1.56 × 1.56 × 2 mm3, TE1 
= 1.17 ms, ΔTE = 1.6 ms, 6 echoes, TR = 25 ms, flip angle 
= 3°, bandwidth 1894 Hz/pixel. Phantoms and subjects were 
also imaged using a similar vendor‐supplied gradient‐echo 
sequence with bipolar readout gradients (Philips, mDixon 
Quant, Philips Healthcare, Andover, MA),10 which provided 
PDFF and R2* maps with the same matrix size and field of 
view as the raw complex data. The mDixon Quant algorithm 
assumes a 10‐peak model of human adipose tissue and a sin-
gle R2* decay term, as previously described.10,11 Multiecho 
images of the new fat‐water phantom were acquired with the 
same sequence used for scanning the fat‐water‐bone phantom 
described above.
Subjects also underwent a standard clinical MRI scan on 
a 1.5T system (Avanto, Siemens, DE) with angled coronal 
(tilted at the same angle as the gradient‐echo images) T1‐ and 
T2‐weighted STIR sequences.21 These images were used only 
as landmarks for the manual segmentation of normal bone 
marrow, bone marrow edema, and fat metaplasia by an expe-
rienced radiology registrar (T.J.P.B.). Susceptibility mapping 
was only applied to the images acquired at 3T.
2.5 | Susceptibility mapping (QSM) pipeline
Susceptibility maps were obtained from all multiecho im-
ages22 using the following, optimized QSM pipeline: (1) 
Three‐point Dixon method23 to estimate a field map without 
fat‐water chemical shift effects, (2) Laplacian phase unwrap-
ping24 to remove temporal and spatial phase aliasing, (3) 
Projection onto dipole fields25 to remove background fields, 
F I G U R E  1  A,B, Fat‐water‐bone phantom. Fat fraction (FF) measurements vary by row, whereas bone mineral density (BMD) measurements 
vary by column. The phantoms were immersed in distilled water for scanning. The larger tubes shown in (A), interspersed between the columns of 
the phantom, contain fat‐water mixtures that were used as a visual check on the quality of fat‐water decomposition (i.e., to exclude fat‐water swaps) 
while optimizing the acquisition
4 |   BRAY et Al.
and (4) direct k‐space inversion using Tikhonov regulariza-
tion26-28 to calculate the susceptibility maps.
The three‐point Dixon method (step 1) requires only three 
equally spaced echoes. We used the first, third, and fifth 
echoes of both the phantom and subject images, as these con-
sistently provided images with the fewest fat‐water swapping 
artifacts by visual inspection. All images were zero‐padded 
to a matrix size of 512 × 512 × 128 before steps 2 and 4 
to avoid errors introduced by the application of direct and 
inverse Fourier transforms in these methods. The tilt of the 
coronal slices was accounted for by defining the dipole ker-
nel to be parallel to the real direction of the main magnetic 
field in steps 3 and 4. The Tikhonov regularization parameter 
was set to α = 0.05 in step 4 based on the optimized value in 
Langkammer et al.26
The background field removal (step 3) requires a binary 
tissue mask. Initial masks were obtained in each case by 
thresholding the inverse noise map calculated from the mul-
tiecho magnitude images27,29 to exclude high‐noise voxels 
that could introduce streaking into the susceptibility maps. 
In the phantoms, artifact‐inducing structures (i.e., the plastic 
struts of the vial holders) were manually segmented in the 
first‐echo magnitude images using ITK‐SNAP30,31 and also 
excluded from the masks. In the patient and volunteer im-
ages, bony voxels were often excluded due to their high noise 
levels. However, this study aimed to calculate susceptibility 
maps in bone marrow so some of these noisy bony voxels 
were of interest. We could have adjusted the threshold for the 
masking step to include these bony areas in the tissue mask, 
but then other noisy, artifact‐inducing voxels (e.g., around 
the tissue/air interfaces in bowel) would be included as well. 
Therefore, we used the original threshold and added the ex-
cluded bone to the tissue mask later.
These bony voxels were identified in all subjects using the 
following scheme: (1) Bones were manually segmented (by 
A.K.) in the first‐echo magnitude image of one of the healthy 
volunteers (subject 1) in ITK‐SNAP.30,31 (2) All scanner‐pro-
vided water images were thresholded so that values in regions 
with low water signal were set to zero. (3) The thresholded 
water image of subject 1 was nonrigidly registered to all other 
thresholded water images using the NiftyReg software32 with 
the weight of the bending energy term increased to 0.01 and 
a final grid size of 7 voxels. (4) Bones were segmented in the 
rest of the images by applying the resulting transformations 
to the manually segmented bone region of subject 1. This 
process provided suitable segmentations in all subjects. We 
used the thresholded water images here, because the shape 
and size of subcutaneous fat largely varied across subjects 
whereas the water images generally looked similar and, 
therefore, provided more accurate registrations around bony 
structures. Additionally, the edges of the patient and volun-
teer tissue masks were eroded by 5 voxels in each slice to 
further improve the quality of the susceptibility maps.
Because QSM calculates the average susceptibility of the 
substances (in other words the volume susceptibility)33,34 
within each voxel, it is expected to have a linear relation-
ship with both fat and bone content (i.e., PDFF and BMD). 
Therefore, we propose a procedure to estimate BMD‐in-
duced susceptibility maps: (1) PDFF and susceptibility maps 
were measured and calculated. (2) Linear regression was 
performed between susceptibility and PDFF in voxels with-
out bony trabeculae. (3) The regression parameters and the 
PDFF map were then used to estimate the contribution of fat 
to susceptibility in every voxel. (4) The contribution of fat 
was subtracted from the total susceptibility map resulting in a 
susceptibility map that is expected to be proportional to BMD 
assuming that no other para‐ or diamagnetic components are 
present. We performed this procedure in all volunteer and 
patient susceptibility maps. Step 2 was carried out in a rect-
angular region, including both water‐based tissue (gluteal 
muscle) and subcutaneous fat, manually selected in the mid-
dle slice in each subject.
To compare the contributions of BMD with susceptibility 
and R2*, a similar procedure was performed for the scanner‐
provided R2* maps. To model the effects of PDFF on the 
measured R2*,8 we adopted an empirical quadratic fit (in-
stead of the aforementioned linear relationship) in step 2 that 
provided better fits.
2.6 | Statistical analysis
For both phantoms, circular regions of interest (ROIs) were 
manually drawn (by A.K.) on the first‐echo magnitude im-
ages in eight consecutive slices near the middle of the ac-
quired volumes using ITK‐SNAP.30,31 Mean susceptibilities 
and R2* values were calculated in all ROIs. The 2D linear 
functions were fitted to the measured susceptibility and R2* 
values as functions of known FF and BMD values in the fat‐
water‐bone phantom. Linear regression was performed be-
tween measured susceptibilities and known FF values in the 
fat‐water phantom.
For the patients and healthy controls, areas of normal bone 
marrow, bone marrow edema, and fat metaplasia were man-
ually segmented on the first‐echo magnitude images using 
landmarks from the T2‐weighted STIR and T1‐weighted im-
ages by an experienced radiology resident (T.J.P.B.) as de-
scribed in Bray et al.8 ROIs that were very close to fat‐water 
chemical shift artifacts in the susceptibility maps were ex-
cluded from the analysis. This included all ROIs from two 
subjects (8 ROIs of fat metaplasia and 4 ROIs of normal bone 
marrow), and two additional ROIs from a third subject (of 7 
ROIs of fat metaplasia). Mean susceptibilities and R2* values 
were calculated in the rest of the segmented ROIs both before 
and after removing the contributions of fat as described above 
(i.e., the same ROIs were used in all four cases). Susceptibility 
values were referenced to the mean susceptibility within the 
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tissue mask for each subject (this mean susceptibility varied 
between −0.01 ppm and 0.01 ppm). Multilevel mixed‐effects 
linear regression was used (in MATLAB R2015a) to deter-
mine whether there were significant differences in suscep-
tibilities and R2* values measured in normal bone marrow, 
edema, and fat metaplasia. This test accounts for repeated 
observations in individual patients.
3 |  RESULTS
3.1 | Phantoms
Images from the fat‐water‐bone phantom are shown in 
Figure 2A,B. Susceptibility measurements were posi-
tively related to FF values and negatively related to BMD 
(Figure 2C, Supporting Information Table S1a), with the 2D 
linear model providing an accurate description of the acquired 
data (adjusted R2 = 0.77; Figure 2C‐F). All coefficients were 
significant (i.e., P < 0.01, Supporting Information Table 
S1a). Similarly, in the lard‐water phantom covering the full 
range of FF values (Figure 3), there was an approximately 
linear relationship (adjusted R2 = 0.82) between FF and sus-
ceptibility (Figure 3C, Supporting Information Table S1b) 
even toward high FF values. Figure 2G shows the 2D linear 
model fitted to the R2* values. In this case, despite the high 
adjusted R2 value (0.81), only the BMD slope was significant 
(Supporting Information Table S1b).
3.2 | Patients and volunteers
Susceptibility values were significantly increased in areas 
of fat metaplasia compared with normal marrow (Figure 
4A). R2* measurements were also significantly reduced 
in areas of fat metaplasia compared with normal marrow 
(Figure 5A), in line with previous results.8 There were no 
significant differences in susceptibility or R2* between 
normal bone marrow and areas of edema. However, sus-
ceptibility values were significantly lower, and R2* val-
ues significantly higher, in areas of edema compared with 
areas of fat metaplasia.
PDFF and susceptibility values within a single, rectan-
gular ROI (overlaid on the susceptibility map) incorporating 
both muscle and subcutaneous fat, in addition to the results of 
the linear regression analysis, are shown for a single subject 
in Figure 6. Similarly, Figure 7 shows R2* and PDFF values 
within the manually selected ROI (overlaid on the R2* map), 
and the results of the nonlinear regression analysis assuming 
F I G U R E  2  Results from the fat‐water‐bone phantom. First‐echo magnitude image and susceptibility map are shown in (A) and (B), 
respectively. The manually drawn circular regions of interest (ROIs) are highlighted in red (A). Results of the 2D linear fit between bone mineral 
density (BMD) and fat fraction (FF) values and susceptibility are shown in (C‐F). In (C), the transparent surface corresponds to measured values, 
while the opaque plane is the fitting 2D linear function. The same is shown for R2* in (G). The fitted model parameters are shown in Supporting 
Information Table S1a, b
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a quadratic relationship. In both Figures 6 and 7, the majority 
of voxels are either almost entirely water based (green arrow 
and dotted circle) or fat based (blue arrow and dotted circle). 
Note that the straight line observed at the upper end of the 
PDFF range in Figure 7 arises due to a lower bound for R2* 
estimates (0.01 ms−1) used by the mDixon Quant algorithm. 
Model parameters from the linear and quadratic fits between 
PDFF and susceptibility, and PDFF and R2*, respectively, 
are shown in Figure 8. The coefficients of the quadratic fit 
(Figure 8B) were highly variable across subjects. While the 
intercept of the linear fit to susceptibility values also showed 
large variations across subjects, the susceptibility‐PDFF 
slope was somewhat consistent for regressions with high ad-
justed R2 measures (Figure 8A, blue circle).
Susceptibility values and R2* measurements after remov-
ing the fat contribution are shown in Figures 9 and 10, respec-
tively. There were no significant differences between normal 
bone marrow and fat metaplasia in either susceptibility or 
R2* maps after performing the adjustment for fat content.
4 |  DISCUSSION
In spondyloarthritis, new bone formation and bone destruc-
tion contribute to spinal ankylosis and osteoporosis, respec-
tively, and are key contributors to morbidity. However, these 
processes cannot be quantified using conventional spin echo 
sequences. In this study, we sought to characterize the rela-
tionship between BMD, FF, and susceptibility measurements 
in inflamed bone marrow, using both phantom and in vivo 
studies with the aim of investigating susceptibility as a po-
tential biomarker of these processes.
In the fat‐water‐bone phantom, we observed linear rela-
tionships between FF and susceptibility and between BMD 
and susceptibility. The linear relationship between FF and 
susceptibility was also observed in a separate, lard‐based fat‐
water phantom covering the full range of FF measurements, 
although there was a slight nonlinear variation which may be 
related to difficulties in manufacturing a homogenous lard‐
water phantom. In accordance with previous studies,12-14,18 
our data indicated positive (paramagnetic) susceptibility val-
ues for fat, and negative (diamagnetic) susceptibility values 
for bone. Our results confirm the feasibility of measuring 
BMD in the bone marrow, and suggest that the contribution 
of fat to the total susceptibility measurement can be modeled 
using a simple linear relationship.
Importantly, the results of our phantom study were used 
to inform the analysis of the in vivo results, to enable us to 
estimate the contribution of the fat to the total susceptibility 
measurement. Using per‐patient linear regression analysis 
in voxels of subcutaneous fat and muscle, we were able to 
remove the fat contribution to susceptibility measurements 
F I G U R E  3  Results from the fat‐water phantom. First‐echo magnitude image and susceptibility map are shown in (A) and (B), respectively. 
The linear fit between fat fraction (FF) and susceptibility values is shown in (C). The fitted model parameters are shown in Supporting Information 
Table S1c
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in areas of fat metaplasia, edema, and normal marrow, and 
thereby interrogate the source of susceptibility differences 
between these regions. Strikingly, we found that susceptibil-
ity measurements were significantly increased in areas of fat 
metaplasia compared with normal marrow, but that this dif-
ference was abolished after removal of the fat contribution. 
This suggests that the contribution of fat content to overall 
susceptibility is likely to be substantial, and highlights the 
importance of accounting for the contribution of fat when 
performing QSM in bone marrow.
Similarly, although there was a significant reduction in 
R2* in areas of fat metaplasia compared with normal mar-
row, no significant difference was observed in fat‐corrected 
R2* measurements. This result suggests that the previously‐
reported reduction in R2*8 in areas of fat metaplasia may 
actually be a secondary effect of varying fat content: as fat 
fraction increases from around 50% (normal bone) to approx-
imately 70‐90% (fat metaplasia),8 the susceptibility distri-
bution inside the voxel becomes more homogenous, and the 
relaxation rate R2* reduces accordingly. This suggestion is in 
keeping with previous results in muscle, which suggest that 
R2* measurements are highest at intermediate PDFF values, 
and are at their lowest at the extremes of the PDFF range (i.e., 
close to 0% and close to 100%).35 In contrast, the linear rela-
tionship of susceptibility with FF suggests that susceptibility 
measurements are less affected by the microscopic (sub‐
voxel) susceptibility distribution, because the susceptibility 
calculation largely relies on larger‐scale phase differences 
outside the voxel. This is potentially a significant advantage 
of QSM over R2* mapping.
Overall, the results of our study highlight that lipids con-
tribute substantially to both susceptibility and R2* estimates 
in trabecular bone, and can at least partly account for the dif-
ferences in susceptibility between regions. Accounting for 
the fat contribution to susceptibility is likely to be essential 
when imaging trabecular bone in general. If the fat contribu-
tion is not separated, changes in susceptibility/R2* might be 
incorrectly attributed to changes in BMD, or other factors.
In this study, we used the individual regression parame-
ters in Figure 8 for each subject to remove the contributions 
of fat from susceptibility and R2* maps. For the R2* maps, 
the quadratic model is a heuristic approximation of the ob-
served shape of the PDFF‐ R2* relationship. Therefore, the 
coefficients vary greatly across subjects (Figure 8B), and the 
F I G U R E  4  Susceptibility maps in patients. Measured mean susceptibilities in areas of normal marrow, edema, and fat metaplasia are shown 
in (A). P‐values were calculated for each pair and the asterisks indicate statistical significance. The four highest susceptibility values in normal bone 
marrow (red circle) were measured in the same subject. Susceptibility maps and magnitude images in example subjects are shown in (B)
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correction is expected to be more accurate if individual fit-
ting parameters are used.
In QSM, the susceptibility of a tissue can only be measured 
relative to the susceptibility of surrounding tissues, and there 
is expected to be variation in this susceptibility offset across 
subjects. This could explain the variability of a0 in Figure 8A. 
Though referencing is used to enable comparison of suscepti-
bility across scans, here we used the mean susceptibility within 
the tissue mask as a reference which might not be ideal. Future 
studies could explore other potential reference tissues in the 
pelvic area similarly to what has been done in the brain.36 This 
could result in more consistent a0 values across subjects. The 
estimated slope (a1 in Figure 8A) seems to be consistent across 
subjects for regressions with high adjusted R2 (Figure 8A, blue 
circle). This is encouraging as the composition of subcutane-
ous fat and, therefore, the relationship between FF and suscep-
tibility is expected to be similar across subjects. In a few cases 
(where the adjusted R2 was lower), the fitted slopes as well 
as the correlation between susceptibility and FF (not shown) 
were substantially lower. This might be due to susceptibility 
errors on the boundary between fat‐ and water‐based tissues 
introduced by the large susceptibility gradient.
Selecting two separate areas (one in subcutaneous fat and 
one in muscle) could be a way of overcoming this problem in 
the future; however, here we needed to include the voxels on 
the boundary (where FF values are between 0.3 and 0.7) to 
be able to appreciate the relationships between FF, and sus-
ceptibility or R2* (Figures 6 and 7). It could be interesting to 
explore if a single slope value can be used to robustly remove 
fat contributions from susceptibility maps. In any case, using 
individual regression parameters was more appropriate here 
as the same approach was implemented for the R2* maps. Of 
interest, the estimated slope values were different in subjects 
than in the fat‐water phantoms (and also varied slightly be-
tween the two phantoms), which might be due to differences 
in susceptibility between different lipids or, in patients, to 
susceptibility contributions from nonlipid molecules in mus-
cle and/or adipose tissue. Further work is required to investi-
gate this issue.
It is not yet known how bone content or structure changes 
in areas of edema and fat metaplasia. In the patients with 
spondyloarthritis investigated here, the fact that we did not 
find a significant difference in fat‐corrected susceptibility in 
areas of fat metaplasia argues against a significant change in 
F I G U R E  5  R2* maps in patients. Mean R2* measurements in areas of normal marrow, edema, and fat metaplasia are shown in (A). P‐values 
were calculated for each pair and the asterisks indicate statistical significance. R2* maps and magnitude images in example subjects are shown in 
(B)
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F I G U R E  6  Linear regression between proton density fat fraction and susceptibility values in a single, representative subject. A rectangular 
ROI including fat and muscle was manually placed on the middle slice of the susceptibility map. Each point in the scatter plot corresponds to one 
voxel within this rectangular region (excluding voxels outside the subject). The blue arrow and dotted circle indicate subcutaneous fat and the 
corresponding points in the scatter plot. The green arrow and dotted circle indicate muscle and the corresponding points in the scatter plot. Results 
from the regression analysis for each subject are shown in Figure 8
F I G U R E  7  Nonlinear regression between PDFF and R2* values using a quadratic model. The R2* map and the regression of a representative 
subject are shown. Each point in the scatter plot corresponds to one voxel within this rectangular region (excluding voxels outside the subject). The 
blue arrow and dotted circle indicate subcutaneous fat and the corresponding points in the scatter plot. The green arrow and dotted circle indicate 
muscle and the corresponding points in the scatter plot. Results from the regression analysis for each subject are shown in Figure 8. Note that 
the straight line of points at the right lower corner of the plot arises due to the lower bound applied to R2* estimates by the mDixon Quant fitting 
algorithm
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BMD in these areas. However, it is also possible that we have 
simply failed to detect this change due to technical limitations 
arising from the acquisition protocol and/or susceptibility 
mapping pipeline such as the removal of chemical‐shift‐in-
duced errors, as discussed in the next paragraph. Also, note 
that the four highest susceptibility values in normal marrow 
(Figure 4A, red circle) were measured in the same subject, so 
these unrealistically high values could be due to a processing 
issue in this subject. We did not find a significant difference 
in susceptibility between areas of edema and normal bone 
F I G U R E  8  Coefficients of the linear and quadratic fits between proton density fat fraction and susceptibility (A) or R2* (B), respectively. 
The fitting function is displayed in the top right corner of both subplots. In all 5 scatter plots, each point corresponds to 1 subject. Coefficients are 
shown as a function of the adjusted R2 of each fit. The error bars indicate the 95% confidence interval of each coefficient. The slope of the linear 
regression (a1) seems to be consistent in instances where the adjusted R2 was high (>0.5, see blue circle). All other parameters had large variations 
across subjects
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marrow. On theoretical grounds, we would have expected 
a reduction in susceptibility (before fat correction) in areas 
of edema due to increased water fraction, which would have 
been expected to disappear after fat correction. However, the 
changes in fat fraction in areas of edema are smaller than 
those observed in fat metaplasia (compared with normal mar-
row),8 which may have prevented detection of this effect.
A limitation of this study is that the fat‐water decomposi-
tion step in the QSM pipeline, aiming to eliminate chemical 
shift effects, suffered from fat‐water swaps in some subjects, 
which may have contributed to inaccuracies in the calculated 
susceptibilities. Swaps may be introduced during the re-
gion‐growing stage of the fat‐water decomposition (Dixon) 
method,37 possibly due to errors or noise in the measured 
phase data. Empirically, we found that the three‐point Dixon 
method used here was the most robust of the available op-
tions in the ISMRM fat‐water toolbox,37 although even this 
did not perform perfectly in all cases. Better results might be 
achieved by using alternative algorithms for fat‐water decom-
position. One option is to use manufacturers’ own algorithms 
for fat‐water decomposition (and to generate field maps), 
but this comes at the cost of reduced flexibility and makes 
it more difficult to translate the approach to other platforms. 
Another possibility is using in‐phase echo timing to remove 
most of the chemical shift phase contributions,38,39 while 
also acquiring opposed‐phase (or partially opposed‐phase) 
images to calculate PDFF maps.
One of the most crucial features of susceptibility mapping 
is the generation of the tissue mask. Noisy voxels are prone 
to introduce far‐reaching streaking artifacts and errors into 
the susceptibility maps. In images of the sacroiliac joint, it is 
very important to properly exclude areas of bowel as the phase 
measured in these voxels is often corrupted by motion artifacts 
and suffers from low signal due to air in the bowel lumen. 
Therefore, thresholding the inverse noise map seems appro-
priate here for generating a suitable tissue mask. However, 
bony voxels are also expected to have low signal. The process 
described here, aiming to keep bony voxels while excluding 
bowel, was simple and provided reasonable tissue masks in 
most cases, but susceptibility accuracy could potentially be 
improved using more accurate, automated bone segmentation 
tools, for example, based on multiatlas information.40
There is a complex relationship between PDFF and R2* 
measurements, which means that changes in R2* in tissue 
F I G U R E  9  Susceptibility maps in patients after removing the fat contribution. Fat‐corrected susceptibility measurements in areas of normal 
marrow, edema and fat metaplasia are shown in (A). P‐values are calculated for each pair. Susceptibility maps and magnitude images in example 
subjects are shown in (B)
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are ambiguous. It might be possible to model this relation-
ship using prior knowledge of fat and water susceptibility 
and the arrangement of fat and water in the tissue, but this 
is not trivial and introduces further sources of complex-
ity. Using susceptibility as a marker of BMD has several 
advantages over R2*. Most importantly, the linear rela-
tionships observed in the fat‐water‐bone phantom enable 
fat‐correction to be performed very simply, and the fat‐cor-
rected susceptibility measurements to be interpreted un-
ambiguously. Future studies could correlate the measured 
bone marrow susceptibilities with gold‐standard, QCT‐
based clinical BMD measures,41 however, this is subject to 
ethical constraints relating to the use of ionizing radiation, 
particularly in young patients.
5 |  CONCLUSIONS
Quantitative susceptibility measurements are linearly related to 
BMD and FF, and failure to remove the fat contribution to sus-
ceptibility measurements can potentially lead to errors in QSM‐
based BMD quantification. We propose a method for removing 
this contribution using a linear fit to susceptibility as a function 
of FF in a region not containing bone. Comparison of data both 
with and without this correction suggest that increased fat con-
tent is the major contributor to the increase in susceptibility in 
areas of fat metaplasia relative to normal bone marrow.
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SUPPORTING INFORMATION
Additional supporting information may be found online in 
the Supporting Information section at the end of the article.
TABLE S1 Fitted model parameters for the two phantoms. 
Result of the 2D linear fit between bone mineral density and 
fat fraction values and susceptibility in the fat‐ water‐bone 
phantom are shown in (A). The same for R2* is shown in (B). 
Results of the linear fit between fat fraction and susceptibility 
in the fat‐water phantom are shown in (C)
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